Ownership & Leadership
Kiamibio is a health technology company founded and led by Kiana Ghaus (CEO) and Amisi Ghaus (CTO), uniting expertise in medicine, biotechnology, artificial intelligence, and holistic wellness. Our mission is to transform how asthma and Crohn’s disease are diagnosed, monitored, and managed through intelligent, integrative solutions. We are building a connected health ecosystem where biosensors, AI-driven analytics, personalized nutrition, yoga, and herbal therapeutics work seamlessly to restore balance and improve long-term outcomes. By combining precision medicine, advanced technology, and ancient wellness wisdom, Kiamibio is pioneering a new model of care — one that makes holistic health measurable, predictive, and accessible for everyone.
*Disclaimer: The charges are centered around delivering holistic health guidance, while biosensor development is still in progress.
Our Expertise
- Integrated Expertise – Bridging pulmonology, gastroenterology, and immunology to address complex immune-driven diseases affecting both lungs and gut.
- Dual-Disease Diagnosis – Specialized in early detection and differentiation of asthma symptoms linked to Crohn’s-related systemic inflammation.
- Biosensor Innovation – Development and use of wearable biosensors to monitor respiratory function, gut health, and inflammatory biomarkers in real time.
- Multidisciplinary Care – Coordinated management across respiratory and gastrointestinal teams for holistic patient outcomes.
- Patient-Centered Approach – Special focus on quality of life, addressing diet, nutrition, and mental health alongside medical therapies.
- Holistic Health Integration – Combining yoga, therapeutic diets, and immuno-modulatory herbs with AI-driven personalized recommendations to optimize lifestyle interventions and immune support.
We are committed to delivering patient-centered, transparent, and future-ready healthcare solutions.